4th Heidelberg Innovation Forum: Call for Papers open

The call for papers for the next Heidelberg Innovation Forum "Europe's innovative convention for the commercialisation and financing of IT research projects" is now open. The central theme of the fourth Heidelberg Innovation Forum on 24/25 April 2007 will be "IT Solutions for Innovative Industries".

Around 100 top IT decision makers from Europe's automotive and mechanical engineering industries and approximately 50 IT researchers are expected to attend. The venues will be the tradition-steeped Villa Bosch close to Heidelberg Castle and Palais Prinz Carl in Heidelberg's old town.

The first three events held in 2005 and 2006 were a great success with researchers and industry representatives alike. Since 2005 transfer business has been successfully realised in spin-offs, licensing business and public-private R&D-partnerships.

IT researchers have the opportunity to

  • present attractive R&D results with high application potential in industry to relevant licensees, to venture capitalists for seed investments and to partners for marketing strategies (matchmaking);
  • present new research projects and ideas for which you are seeking suitable investors and partners in industry (project pitch);
  • foster personal contacts with decision makers from enterprises as well as with colleagues (networking).

IT researchers that would like to present their research results at the Heidelberg Innovation Forum can apply as follows:

  • In response to our call for proposals, please submit one or more proposals for the presentation of R&D results and/or project ideas using the reply form available at http://www.mfg-innovation.com/mfg-hif-call.html by 12 January 2007 at the latest. The conference fee of EUR 350 plus VAT will be waived for all those invited to attend. The project selection process will be completed by the beginning of February.
  • In addition, if you support us by advertising the Heidelberg Innovation Forum with decision makers in industry, hotel accommodation in Heidelberg can also be booked at our expense. Please refer to the reply form for full details.
  • A professional coaching workshop is offered on 9 March 2007 to presenters of the Heidelberg Innovation Forum. It is to be conducted by Ms Tanja Fury, Auxell Coaching.

The Heidelberg Innovation Forum is sponsored by the State of Baden- Württemberg and the European Media Laboratory, the research institute for trendsetting information technology established by SAP founder Dr Klaus Tschira. Based on the current concept of Open Innovation (Harvard), it offers a unique platform for matchmaking between researchers and decision makers in industry who are on the lookout for new ideas. Representatives from the world of science can profit from the event to canvas for third-party funds, thus ensuring the stability of their own financial position.

For further questions, please do not hesitate to contact Dr. Bernd Janson, Project Manager (This email address is being protected from spambots. You need JavaScript enabled to view it., phone +49 (0)711 / 90715-329).

For further information, please visit:
http://www.heidelbergerinnovationsforum.de

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...